In Order to Buy Investigational Weight-Loss Drugs, a Group of Americans Learn to Use Bitcoin Payments
To purchase the experimental weight-loss drug retatrutide, Americans like Zach are turning to Bitcoin despite initial skepticism. Retatrutide, an unapproved triple-agonist from Eli Lilly, offers significant weight loss but is inaccessible through U.S. channels. Buying from domestic resellers costs around $3,600 annually, whereas Zach found a Chinese seller offering a year’s supply for $240—with Bitcoin as the only payment option. This price disparity led him to learn cryptocurrency for the transaction.
Online sellers of such “research chemicals” or peptides often use Bitcoin because traditional payment systems avoid the regulatory and legal risks. Chainalysis data shows crypto payments to grey-market peptide sellers reached $32 million in Q1 2026, suggesting an annualized volume exceeding $100 million, though this remains a fraction of the estimated $1-3 billion black market.
The trend intersects with communities like DeSciNYC, where events on peptides draw crowds interested in biohacking and longevity, indicating shared interests between crypto and wellness circles. However, potential FDA moves to legalize certain peptides could shift demand away from the black market and reduce the need for crypto payments.
marsbit07/22 01:56
